Evidence map›Paper›PMID 36326214›Full record

ReviewImmunological reviews2023

Neutrophil-T cell crosstalk and the control of the host inflammatory response.

Serena Bert, Suchita Nadkarni, Mauro Perretti

Open access · hybridAbstract readReview
In one paragraph

Review in Immunological reviews, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Neutrophils in cancer.Nature reviews. Cancer · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Characterizing trajectories of innate immune cells in larval zebrafish.bioRxiv : the preprint server for biology · 2025
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Serena BertThe William Harvey Research Institute, Queen Mary University of London, London, UK.
Suchita NadkarniThe William Harvey Research Institute, Queen Mary University of London, London, UK.
Mauro PerrettiThe William Harvey Research Institute, Queen Mary University of London, London, UK.ORCID 0000-0003-2068-3331
Queen Mary University of London · GB

Funding

British Heart Foundation FS/17/1/32528British Heart Foundation FS/4yPhD/F/20/34133Medical Research Council MR/P026362/1
6 · The paper itself

Abstract

While fundamental in their innate role in combating infection and responding to injury, neutrophils are emerging as key modulators of adaptive immune responses. Such functions are attained via both soluble and nonsoluble effectors that enable at least two major downstream outcomes: first, to mediate and control acute inflammatory responses and second, to regulate adaptive immunity and ultimately promoting the development and maintenance of immune tolerance either by releasing immuno-modulatory factors, including cytokines, or by directly interacting with cells of the adaptive immune system. Herein, we review these novel properties of neutrophils and redefine the pathophysiological functions of these fascinating multi-tasking cells, exploring the different mechanisms through which neutrophils are able to either enhance and orchestrate T cell pro-inflammatory responses or inhibit T cell activity to maintain immune tolerance.

Indexed as

Immunity, InnateNeutrophilsAdaptive ImmunityHumansInflammationT-Lymphocytesautoimmunityimmune-mediated diseasesimmunosuppressioninflammationpregnancy

Identifiers

PMID36326214
PMCPMC10952212
OpenAlexW4308056067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.